UBS(L)Eq.SICAV Ch.H.C(USD)P a.USD/ LU2389358735 /
| NAV2024-06-04 | Chg.+0.9500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 58.4100USD | +1.65% | reinvestment | Equity Sector Health / Pharma | UBS Fund M. (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -12.29 | 2.10 | -2.25 | -8.79 | 0.15 | 11.92 | -4.31 | -4.83 | -15.60 | -7.16 | 23.12 | 6.93 | -15.93% |
| 2023 | 10.50 | -9.59 | -4.08 | 0.17 | -7.90 | -2.41 | 4.84 | -5.36 | 1.04 | 3.05 | 2.45 | -5.28 | -13.50% |
| 2024 | -14.64 | 7.53 | -6.58 | 0.74 | -2.46 | 1.69 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 20.30% | 20.09% | 20.71% | -% | -% |
| Sharpe ratio | -1.70 | -1.60 | -1.04 | - | - |
| Best month | +7.53% | +7.53% | +7.53% | +23.12% | - |
| Worst month | -14.64% | -14.64% | -14.64% | -15.60% | - |
| Maximum loss | -17.58% | -19.69% | -24.66% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| UBS(L)Eq.SICAV Ch.H.C(USD)Q a.US... | reinvestment | 59.6800 | -16.95% | - | |
| UBS(L)Eq.SICAV Ch.H.C(USD)P a.US... | reinvestment | 58.4100 | -17.66% | - | |
| UBS(L)Eq.SICAV Ch.H.C(USD)UX a.U... | reinvestment | 7,719.9302 | -15.85% | - |
Performance
| YTD | -14.33% | ||
|---|---|---|---|
| 6 Months | -15.36% | ||
| 1 Year | -17.66% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -41.58% | ||
| Year | |||
| 2023 | -13.50% | ||
| 2022 | -15.93% | ||
